临床输血与检验Issue(1)：32-34,3.DOI:10.3969/j.issn.1671-2587.2016.01.011
血清标记物联合检测对肝癌的临床诊断价值
The Clinical Value of Combined Detection of Serum Tumor Markers in Diagnosis of Liver Cancer
叶芳 1计海芬 1罗锐 2汪学龙3
作者信息
- 1. 230000 中科院合肥研究院肿瘤医院检验科
- 2. 合肥市第一人民医院检验科
- 3. 安徽医科大学病原生物学教研室
- 折叠
摘要
Abstract
Objective To explore the clinical value in combined detection of the serum tumor markers on patients with hepatocellular carcinoma.Methods56 cases primary liver cancer of the hospitalized patients,32 cases of other liver diseases, and34 healthy persons were collected. Carcinoembryonic antigen (CEA), serum malignant tumor growth factor (TSGF), glutamate based transpeptidase (GGT), alpha fetoprotein (AFP)and fucosidase (AFU) were determined.Results Indexes AFP, TSGF, AFU, GGT and CEA in patients with primary liver cancer were higher than those with benign liver diseases and normal control (P<0.05). The sensitivity and specificity of combined detection were higher than those of the single test (P <0.05).Conclusion The combined detection of serum tumor markers of liver cancer can effectively improve the accuracy of diagnosis, and provide important basis for the differential diagnosis of hepatocellular carcinoma.关键词
肿瘤标记物/肝癌/诊断/检测Key words
Serum tumor marker/Liver cancer/Diagnosis Detection分类
医药卫生引用本文复制引用
叶芳,计海芬,罗锐,汪学龙..血清标记物联合检测对肝癌的临床诊断价值[J].临床输血与检验,2016,(1):32-34,3.
